Welcome to our dedicated page for AEHR TEST SYSTEMS SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
The Caroline J. Scott Revocable Trust Agreement intends to sell up to 20,000 shares of AEHR common stock through Fidelity Brokerage Services, with an aggregate market value of $2,630,305.62, on or after August 12, 2026 on NASDAQ. These shares were acquired in a private placement from the issuer on December 18, 2015 for cash. The trust also reports that 20,000 shares of common stock were sold on July 16, 2026 for $1,642,649.44.
An affiliate of AEHR filed a notice of proposed sale of restricted shares. The filing lists 1,717 shares of common stock to be sold through Fidelity Brokerage Services LLC on NASDAQ, with an aggregate market value of $228,361.17 and a proposed sale date of 08/12/2026.
The securities to be sold originated from restricted stock vesting awards treated as compensation, including 1,159 shares vesting on 07/11/2025 and 558 shares vesting on 07/27/2025.
Aehr Test Systems (AEHR) filed a notice of proposed sale under Rule 144 for up to 40,000 shares of common stock to be sold through Fidelity Brokerage Services LLC on 08/12/2026 on NASDAQ, with an aggregate market value of $5,233,716.34. The filing also lists prior issuances of common stock as compensation via restricted stock vesting on several dates in 2021 and 2022, including 28,168 shares on 08/13/2021, 2,082 shares on 04/01/2022, 5,489 shares on 04/20/2022, 2,044 shares on 07/13/2022, and 2,217 shares on 10/03/2022.
AEHR TEST SYSTEMS executive Alistair N. Sporck, VP Contactor Business Unit, reported selling 1,000 shares of common stock on 2026-08-10 at $108.49 per share. After the sale, he holds 22,547 directly (including unvested restricted stock units) and 5,177 shares indirectly through a trust.
AEHR insider Alistair N. Sporck filed a notice to sell 1,000 shares of common stock through Fidelity Brokerage Services on NASDAQ on or after 08/10/2026. The filing also lists 1,000 shares from restricted stock vesting on 07/01/2026 as compensation and discloses a prior sale of 2,000 shares for $201,916.91 on 08/04/2026 within the last three months.
Aehr Test Systems officer Alistair N. Sporck, Vice President of the Contactor Business Unit, reported selling a total of 2,000 shares of common stock on 2026-08-04 in two open-market transactions at $100.695 and $101.10 per share. The filing also reports 5,177 shares held indirectly by a trust, and notes that one reported share amount includes unvested restricted stock units.
FMR LLC and Abigail P. Johnson report passive ownership of AEHR TEST SYSTEMS common stock in an amended Schedule 13G filing. FMR LLC is shown as beneficially owning 1,006,830.02 shares of common stock, representing 3.2% of the class as of June 30, 2026.
FMR LLC has sole dispositive power over 1,006,830.02 shares and sole voting power over 1,004,568 shares, with no shared voting or dispositive power. Abigail P. Johnson is reported with sole dispositive power over 1,006,830.02 shares, no voting power, and an identical 3.2% beneficial ownership interest.
The filing notes that one or more other persons have rights to receive dividends or sale proceeds from these shares, but no other single person holds an interest exceeding five percent of AEHR TEST SYSTEMS’ outstanding common stock.
Howard T. Slayen, a director of Aehr Test Systems, sold 20,000 shares of common stock on 2026-08-04 at an average price of $108.2961 per share in a sale classified as an open-market or private transaction. Following the sale, he directly holds 146,367 shares, which include shares subject to unvested restricted stock units.